Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank Cichocki

Showing results (1-10 of 62) with videos related to

Pageof 7
Sort By:
Transplantation and Cellular Therapy|March 30, 2021
Impact of Adaptive NK Cells in Donor Lymphocyte Infusions for the Treatment of Hematological MalignanciesFrank Cichocki
Cell Research|July 12, 2022
Promoting T and NK cell attack: preserving tumor MICA/B by vaccinesFrank Cichocki, Jeffrey S Miller
The Journal of Clinical Investigation|April 16, 2019
Setting traps for NKG2A gives NK cell immunotherapy a fighting chanceFrank Cichocki, Jeffrey S Miller
Methods in Molecular Biology (Clifton, N.J.)|December 25, 2009
In vitro development of human Killer-Immunoglobulin Receptor-positive NK cellsFrank Cichocki, Jeffrey S Miller
The Journal of Clinical Investigation|August 1, 2024
Striking a balance: the Goldilocks effect of CD8α expression on NK cellsPaarth B Dodhiawala, Frank Cichocki
Seminars in Immunology|March 6, 2014
NK cell development and function--plasticity and redundancy unleashedFrank Cichocki, Ewa Sitnicka, Yenan T Bryceson
Frontiers in Immunology|September 27, 2019
Human NK Cell Development: One Road or Many?Frank Cichocki, Bartosz Grzywacz, Jeffrey S Miller
The Journal of Allergy and Clinical Immunology|April 12, 2025
Chimeric antigen receptor therapies: Development, design, and implementationMadeline J Lee, Frank Cichocki, Jeffrey S Miller
Journal of Innate Immunity|March 18, 2011
Killer immunoglobulin-like receptor transcriptional regulation: a fascinating dance of multiple promotersFrank Cichocki, Jeffrey S Miller, Stephen K Anderson
Trends in Immunology|May 11, 2016
Epigenetic Regulation of Adaptive NK Cell DiversificationBianca Tesi, Heinrich Schlums, Frank Cichocki, et al.
Pageof 7

Showing results (1-10 of 62) with videos related to

Sort By:
Pageof 7
Transplantation and Cellular Therapy|March 30, 2021
Impact of Adaptive NK Cells in Donor Lymphocyte Infusions for the Treatment of Hematological MalignanciesFrank Cichocki
Cell Research|July 12, 2022
Promoting T and NK cell attack: preserving tumor MICA/B by vaccinesFrank Cichocki, Jeffrey S Miller
The Journal of Clinical Investigation|April 16, 2019
Setting traps for NKG2A gives NK cell immunotherapy a fighting chanceFrank Cichocki, Jeffrey S Miller
Methods in Molecular Biology (Clifton, N.J.)|December 25, 2009
In vitro development of human Killer-Immunoglobulin Receptor-positive NK cellsFrank Cichocki, Jeffrey S Miller
The Journal of Clinical Investigation|August 1, 2024
Striking a balance: the Goldilocks effect of CD8α expression on NK cellsPaarth B Dodhiawala, Frank Cichocki
Seminars in Immunology|March 6, 2014
NK cell development and function--plasticity and redundancy unleashedFrank Cichocki, Ewa Sitnicka, Yenan T Bryceson
Frontiers in Immunology|September 27, 2019
Human NK Cell Development: One Road or Many?Frank Cichocki, Bartosz Grzywacz, Jeffrey S Miller
The Journal of Allergy and Clinical Immunology|April 12, 2025
Chimeric antigen receptor therapies: Development, design, and implementationMadeline J Lee, Frank Cichocki, Jeffrey S Miller
Journal of Innate Immunity|March 18, 2011
Killer immunoglobulin-like receptor transcriptional regulation: a fascinating dance of multiple promotersFrank Cichocki, Jeffrey S Miller, Stephen K Anderson
Trends in Immunology|May 11, 2016
Epigenetic Regulation of Adaptive NK Cell DiversificationBianca Tesi, Heinrich Schlums, Frank Cichocki, et al.
Pageof 7